268 related articles for article (PubMed ID: 8097805)
21. Assessment of functional low-density lipoprotein receptor activity on lymphocytes of normal subjects and patients with familial hypercholesterolemia.
Cuthbert JA; Lipsky PE
Trans Assoc Am Physicians; 1988; 101():1-11. PubMed ID: 3269672
[TBL] [Abstract][Full Text] [Related]
22. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
[TBL] [Abstract][Full Text] [Related]
23. Homozygous familial hypercholesterolaemia: update on management.
France M
Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels.
Koivisto PV; Koivisto UM; Miettinen TA; Kontula K
Arterioscler Thromb; 1992 May; 12(5):584-92. PubMed ID: 1315570
[TBL] [Abstract][Full Text] [Related]
25. Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia.
Guay SP; Brisson D; Lamarche B; Gaudet D; Bouchard L
Epigenetics; 2014 May; 9(5):718-29. PubMed ID: 24504152
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia.
Vohl MC; Gaudet D; Moorjani S; Tremblay G; Perron P; Gagné C; Lesiège D; Bergeron J; Lupien PJ; Després JP
Eur J Clin Invest; 1997 May; 27(5):366-73. PubMed ID: 9179542
[TBL] [Abstract][Full Text] [Related]
27. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
Soutar AK; McCarthy SN; Seed M; Knight BL
J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia.
Dugi KA; Feuerstein IM; Hill S; Shih J; Santamarina-Fojo S; Brewer HB; Hoeg JM
Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):354-64. PubMed ID: 9081692
[TBL] [Abstract][Full Text] [Related]
29. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
Breier C; Lisch HJ; Drexel H; Braunsteiner H
Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
[TBL] [Abstract][Full Text] [Related]
30. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
31. Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.
Dane-Stewart CA; Watts GF; Mamo JC; Dimmitt SB; Barrett PH; Redgrave TG
Eur J Clin Invest; 2001 Feb; 31(2):113-7. PubMed ID: 11168448
[TBL] [Abstract][Full Text] [Related]
32. Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
Ando H; Nishimura Y; Nemoto T; Takamura T; Nagai Y; Kobayashi K
Endocr J; 2001 Feb; 48(1):113-8. PubMed ID: 11403097
[TBL] [Abstract][Full Text] [Related]
33. A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.
Vergopoulos A; Bajari T; Jouma M; Knoblauch H; Aydin A; Bähring S; Mueller-Myhsok B; Dresel A; Joubran R; Luft FC; Schuster H
Eur J Hum Genet; 1997; 5(5):315-23. PubMed ID: 9412789
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
Page MM; Stefanutti C; Sniderman A; Watts GF
Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
[TBL] [Abstract][Full Text] [Related]
35. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
36. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
[TBL] [Abstract][Full Text] [Related]
37. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
[TBL] [Abstract][Full Text] [Related]
38. Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.
Vuorio A; Kovanen PT
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513705
[TBL] [Abstract][Full Text] [Related]
39. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.
Jarauta E; Mateo-Gallego R; Gilabert R; Plana N; Junyent M; de Groot E; Cenarro A; Masana L; Ros E; Civeira F
Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):591-7. PubMed ID: 21196102
[TBL] [Abstract][Full Text] [Related]
40. Diversity in expression of heterozygous familial hypercholesterolemia. Characterization of a unique kindred.
Levy RA; Ostlund RE; Semenkovich CF; Witztum JL
J Clin Invest; 1986 Jul; 78(1):96-101. PubMed ID: 3722389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
